AR053359A1 - Sintesis y preparaciones de polimorfos de aripiprazol cristalino - Google Patents
Sintesis y preparaciones de polimorfos de aripiprazol cristalinoInfo
- Publication number
- AR053359A1 AR053359A1 ARP060101486A ARP060101486A AR053359A1 AR 053359 A1 AR053359 A1 AR 053359A1 AR P060101486 A ARP060101486 A AR P060101486A AR P060101486 A ARP060101486 A AR P060101486A AR 053359 A1 AR053359 A1 AR 053359A1
- Authority
- AR
- Argentina
- Prior art keywords
- synthesis
- polymorphes
- aripiprazol
- preparations
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Formas polimorfas cristalinas de aripiprazol, procesos de síntesis para su preparacion y composiciones farmacéuticas que las contienen. Estas formas cristalinas de aripiprazol pueden molerse fácilmente y se pueden combinar fácilmente con diferentes coadyuvantes farmacéuticos sin realizar cambios en su estructura cristalina, por ejemplo, cuando se comprimen para darles forma de cápsula o tableta
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67152405P | 2005-04-15 | 2005-04-15 | |
US73612805P | 2005-11-14 | 2005-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR053359A1 true AR053359A1 (es) | 2007-05-02 |
Family
ID=37084716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060101486A AR053359A1 (es) | 2005-04-15 | 2006-04-17 | Sintesis y preparaciones de polimorfos de aripiprazol cristalino |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090247542A1 (es) |
EP (1) | EP1879865A1 (es) |
AR (1) | AR053359A1 (es) |
CA (1) | CA2605128A1 (es) |
IL (1) | IL186617A0 (es) |
WO (1) | WO2007004061A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7714129B2 (en) | 2003-12-16 | 2010-05-11 | Teva Pharmaceutical Industries Ltd. | Methods of preparing anhydrous aripiprazole form II |
PL1808164T3 (pl) | 2006-01-05 | 2009-06-30 | Teva Pharma | Sposób z granulacją na mokro do wytwarzania kompozycji farmaceutycznych aripiprazolu |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
ES2401603T3 (es) * | 2006-10-24 | 2013-04-23 | Cambrex Charles City, Inc. | Procedimiento para preparar aripiprazol anhidro de tipo l |
EP2238976B1 (en) | 2009-04-03 | 2012-06-27 | Hexal AG | Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof |
CN102106826B (zh) * | 2009-12-29 | 2013-06-05 | 上海中西制药有限公司 | 一种阿立哌唑固体制剂及其制备方法 |
WO2016181406A1 (en) * | 2015-05-08 | 2016-11-17 | Davuluri Ramamohan Rao | Improved process for the preparation of aripiprazole with reduced particle size |
CN114177868A (zh) * | 2021-12-14 | 2022-03-15 | 辰欣药业股份有限公司 | 一种阿立哌唑的制备方法及装置 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR033485A1 (es) * | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
EP1606262A1 (en) * | 2003-03-21 | 2005-12-21 | Hetero Drugs Limited | Novel crystalline forms of aripiprazole |
US20060270683A1 (en) * | 2003-04-25 | 2006-11-30 | Lohray Braj B | Polymorphs of aripiprazole |
WO2005009990A1 (en) * | 2003-07-25 | 2005-02-03 | Hetero Drugs Limited | Aripiprazole crystalline forms |
WO2005058835A2 (en) * | 2003-12-16 | 2005-06-30 | Teva Pharmaceutical Industries Ltd. | Methods of preparing aripiprazole crystalline forms |
WO2006012237A2 (en) * | 2004-06-25 | 2006-02-02 | Shanghai Institute Of Pharmaceutical Industry | Aripiprazole crystaline forms and associated methods |
WO2006053780A1 (en) * | 2004-11-18 | 2006-05-26 | Synthon B.V. | Crystalline aripiprazole solvates |
EP1686117A1 (en) * | 2005-01-27 | 2006-08-02 | Sandoz AG | Polymorph and solvates of aripiprazole |
-
2006
- 2006-04-13 EP EP06795321A patent/EP1879865A1/en not_active Withdrawn
- 2006-04-13 CA CA002605128A patent/CA2605128A1/en not_active Abandoned
- 2006-04-13 US US11/911,623 patent/US20090247542A1/en not_active Abandoned
- 2006-04-13 WO PCT/IB2006/002301 patent/WO2007004061A1/en active Application Filing
- 2006-04-17 AR ARP060101486A patent/AR053359A1/es unknown
-
2007
- 2007-10-11 IL IL186617A patent/IL186617A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1879865A1 (en) | 2008-01-23 |
US20090247542A1 (en) | 2009-10-01 |
CA2605128A1 (en) | 2007-01-11 |
IL186617A0 (en) | 2008-01-20 |
WO2007004061A1 (en) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR053359A1 (es) | Sintesis y preparaciones de polimorfos de aripiprazol cristalino | |
CU20060039A7 (es) | Forma cristalina beta del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que la contienen | |
CU23616B7 (es) | Forma cristalina gamma del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
BRPI0817597A2 (pt) | Compostos de diarila de oxadiazol, processo para sua preparação, composições farmacêuticas e kit compreendendo os mesmos, bem como seus usos | |
SV2008003088A (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen | |
GT200600258A (es) | Derivados de n-(piridin-2-il)-sulfonamida | |
BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
BRPI0514731A (pt) | derivados de pirimidina | |
ECSP088750A (es) | Métodos y composiciones para antagonismo de rage | |
CL2008001839A1 (es) | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. | |
CL2006001266A1 (es) | Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas. | |
TW200732323A (en) | Organic compounds | |
HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
ECSP078030A (es) | Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona | |
ECSP066915A (es) | Forma cristalina delta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmaceuticas que la contienen | |
CL2004000303A1 (es) | Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih. | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
JO2770B1 (en) | Organic compounds | |
UY32673A (es) | Nuevas pirimidinas, composiciones farmaceuticas que las contienen, procedimientos de preparaciones y su aplicacion como medicamentos | |
DE602006017724D1 (de) | Salicylsäurederivate | |
CR10229A (es) | Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
DK1642897T3 (da) | Alfa-krystalform af strontiumranelat, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
ITMI20061672A1 (it) | Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita' | |
WO2006136580A3 (en) | 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels | |
UY34854A (es) | Inhibidores del transporte de glucosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |